See more : Wisdom Marine Lines Co., Limited (2637.TW) Income Statement Analysis – Financial Results
Complete financial analysis of Astrotech Corporation (ASTC) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Astrotech Corporation, a leading company in the Aerospace & Defense industry within the Industrials sector.
You may be interested
- Corvus Gold Inc. (KOR.TO) Income Statement Analysis – Financial Results
- Telephone and Data Systems, Inc. (TDS-PV) Income Statement Analysis – Financial Results
- Guangdong Topstrong Living Innovation and Integration Co., Ltd. (300749.SZ) Income Statement Analysis – Financial Results
- SLM Corporation (SLMBP) Income Statement Analysis – Financial Results
- Simplex Papers Limited (SIMPLXPAP.BO) Income Statement Analysis – Financial Results
Astrotech Corporation (ASTC)
About Astrotech Corporation
Astrotech Corporation operates as a science and technology development and commercialization company worldwide. It operates through three segments, Astrotech Technologies, Inc. (ATI), 1st Detect Corporation (1st Detect), and AgLAB Inc (AgLAB). The ATI segment owns and licenses the AMS Technology, the platform mass spectrometry technology. The 1st Detect segment manufactures explosives and narcotics trace detectors for use at airports, secured facilities, and borders. This segment provides TRACER 1000, a mass spectrometer based explosives trace detector to replace the explosives trace detectors used at airports, cargo and secured facilities, and borders. The AgLAB segment develops AgLAB-1000, a mass spectrometer for use in the hemp and cannabis market. It also develops BreathTest-1000, a breath analysis tool to screen for volatile organic compound metabolites found in a person's breath. The company was formerly known as SPACEHAB, Inc. and changed its name to Astrotech Corporation in 2009. Astrotech Corporation was incorporated in 1984 is based in Austin, Texas.
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1995 | 1994 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.66M | 750.00K | 869.00K | 334.00K | 488.00K | 127.00K | 86.00K | 2.33M | 2.67M | 513.00K | 16.42M | 24.00M | 26.14M | 20.15M | 27.98M | 31.99M | 25.54M | 52.76M | 50.75M | 59.40M | 77.61M | 94.96M | 102.77M | 105.25M | 105.71M | 107.70M | 64.10M | 56.60M | 46.10M | 43.80M |
| Cost of Revenue | 913.00K | 444.00K | 677.00K | 298.00K | 449.00K | 90.00K | 36.00K | 1.29M | 2.33M | 424.00K | 10.71M | 15.68M | 18.79M | 13.67M | 12.86M | 15.72M | 19.54M | 51.03M | 46.86M | 47.16M | 45.68M | 78.79M | 81.77M | 92.24M | 79.18M | 81.80M | 29.20M | 23.90M | 14.80M | 24.23M |
| Gross Profit | 751.00K | 306.00K | 192.00K | 36.00K | 39.00K | 37.00K | 50.00K | 1.04M | 339.00K | 89.00K | 5.72M | 8.31M | 7.35M | 6.48M | 15.12M | 16.26M | 6.00M | 1.73M | 3.89M | 12.24M | 31.93M | 16.17M | 21.01M | 13.01M | 26.53M | 25.90M | 34.90M | 32.70M | 31.30M | 19.57M |
| Gross Profit Ratio | 45.13% | 40.80% | 22.09% | 10.78% | 7.99% | 29.13% | 58.14% | 44.46% | 12.69% | 17.35% | 34.82% | 34.64% | 28.11% | 32.17% | 54.04% | 50.84% | 23.50% | 3.28% | 7.67% | 20.61% | 41.14% | 17.03% | 20.44% | 12.36% | 25.09% | 24.05% | 54.45% | 57.77% | 67.90% | 44.69% |
| Research & Development | 6.79M | 5.59M | 2.78M | 2.69M | 3.44M | 3.58M | 6.07M | 5.59M | 6.47M | 3.23M | 2.51M | 2.08M | 2.57M | 3.83M | 2.80M | 2.33M | 1.38M | 801.00K | 410.00K | 77.00K | 223.00K | 118.00K | 383.00K | 393.00K | 2.44M | 3.60M | 2.60M | 1.30M | 100.00K | 0.00 |
| General & Administrative | 1.36M | 1.46M | 1.50M | 0.00 | 0.00 | 0.00 | 5.63M | 7.51M | 7.71M | 12.97M | 8.89M | 6.79M | 7.07M | 8.40M | 12.17M | 9.76M | 9.15M | 9.88M | 10.67M | 9.38M | 10.91M | 41.17M | 18.74M | 21.80M | 17.83M | 14.60M | 13.70M | 8.60M | 4.60M | 5.06M |
| Selling & Marketing | 5.88M | 4.32M | 4.50M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 800.00K | 0.00 |
| SG&A | 7.24M | 5.78M | 6.01M | 4.74M | 4.72M | 4.88M | 5.63M | 7.51M | 7.71M | 12.97M | 8.89M | 6.79M | 7.07M | 8.40M | 12.17M | 9.76M | 9.15M | 9.88M | 10.67M | 9.38M | 10.91M | 41.17M | 18.74M | 21.80M | 17.83M | 14.60M | 13.70M | 8.60M | 5.40M | 5.06M |
| Other Expenses | 0.00 | 1.42M | 265.00K | 215.00K | 0.00 | 0.00 | 1.66M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 213.00K | 3.88M | 0.00 | -7.74M | 10.07M | 50.27M | 770.00K | 0.00 | 8.75M | 7.50M | 5.80M | 10.20M | 6.20M | 0.00 |
| Operating Expenses | 14.03M | 11.37M | 8.79M | 7.43M | 8.15M | 8.45M | 11.69M | 13.10M | 14.18M | 16.20M | 11.40M | 8.87M | 9.64M | 12.24M | 14.97M | 12.09M | 10.74M | 14.56M | 11.08M | 1.72M | 21.21M | 91.55M | 19.89M | 22.19M | 29.02M | 25.70M | 22.10M | 20.10M | 13.90M | 5.06M |
| Cost & Expenses | 14.94M | 11.81M | 9.46M | 7.73M | 8.60M | 8.54M | 11.73M | 14.39M | 16.51M | 16.62M | 22.10M | 24.55M | 28.43M | 25.90M | 27.83M | 27.81M | 30.28M | 65.59M | 57.94M | 48.87M | 66.88M | 170.34M | 101.66M | 114.43M | 108.20M | 107.50M | 51.30M | 44.00M | 28.70M | 29.29M |
| Interest Income | 0.00 | 0.00 | 0.00 | 275.00K | 197.00K | 25.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 114.66K | 0.00 |
| Interest Expense | 0.00 | 0.00 | 265.00K | 235.00K | 197.00K | 0.00 | 0.00 | 0.00 | 0.00 | 224.00K | 0.00 | 164.00K | 1.03M | 279.00K | 459.00K | 622.00K | 427.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.36M | 0.00 |
| Depreciation & Amortization | 874.00K | 489.00K | 236.00K | 55.00K | 189.00K | 268.00K | 765.00K | 731.00K | 572.00K | 320.00K | 2.31M | 2.12M | 2.24M | 2.32M | 2.14M | 2.21M | 2.67M | 6.36M | 6.06M | 5.53M | 5.88M | 9.39M | 13.41M | 10.57M | 8.75M | 7.50M | 5.80M | 10.20M | 8.50M | 0.00 |
| EBITDA | -12.41M | -10.69M | -8.36M | -7.31M | -7.58M | -8.15M | -10.88M | -11.33M | -13.43M | -15.79M | -10.18M | 1.56M | -47.00K | -3.44M | 2.29M | 7.05M | -4.73M | -5.71M | -792.00K | 16.05M | 16.61M | -66.00M | 14.53M | 1.40M | 6.26M | 7.70M | 18.60M | 22.80M | 25.80M | 14.51M |
| EBITDA Ratio | -745.55% | -1,474.67% | -989.07% | -2,223.35% | -1,553.48% | -6,627.56% | -10,681.40% | -486.64% | -496.67% | -3,078.17% | -20.50% | 6.48% | -0.18% | -17.07% | 8.18% | 22.03% | 110.96% | -4.91% | -2.22% | 13.99% | 34.38% | -16.56% | 14.89% | 1.33% | 5.92% | 7.15% | 22.93% | 37.10% | 55.97% | 33.13% |
| Operating Income | -13.28M | -11.06M | -8.60M | -7.40M | -8.11M | -8.42M | -13.34M | -12.06M | -13.84M | -16.11M | -5.68M | -559.00K | -2.29M | -5.76M | 153.00K | 4.17M | -4.73M | -12.83M | -7.19M | 10.53M | 10.72M | -75.38M | 1.12M | -9.18M | -2.50M | 200.00K | 12.80M | 12.60M | 17.40M | 14.51M |
| Operating Income Ratio | -798.08% | -1,474.67% | -989.07% | -2,214.67% | -1,662.70% | -6,627.56% | -15,508.14% | -518.04% | -518.08% | -3,140.55% | -34.59% | -2.33% | -8.76% | -28.56% | 0.55% | 13.04% | -18.52% | -24.32% | -14.17% | 17.72% | 13.82% | -79.38% | 1.09% | -8.72% | -2.36% | 0.19% | 19.97% | 22.26% | 37.74% | 33.13% |
| Total Other Income/Expenses | 1.62M | 1.42M | 265.00K | -206.00K | -197.00K | 25.00K | 86.00K | 306.00K | 379.00K | 224.00K | -182.00K | -164.00K | -1.03M | -279.00K | -459.00K | 43.00K | -30.62M | -3.53M | -5.17M | -5.42M | -8.14M | -7.25M | -5.53M | -4.49M | -3.11M | -3.30M | -700.00K | 1.00M | -1.36M | -14.51M |
| Income Before Tax | -11.66M | -9.64M | -8.33M | -7.60M | -8.31M | -8.39M | -13.25M | -11.75M | -13.46M | -15.89M | -5.86M | -723.00K | -3.32M | -6.03M | -306.00K | 4.22M | -35.35M | 16.36M | -12.37M | 5.10M | 2.58M | -82.63M | -4.42M | -13.67M | -5.61M | -3.10M | 12.10M | 13.60M | 16.00M | 0.00 |
| Income Before Tax Ratio | -700.96% | -1,285.60% | -958.57% | -2,276.35% | -1,703.07% | -6,607.87% | -15,408.14% | -504.90% | -503.89% | -3,096.88% | -35.69% | -3.01% | -12.69% | -29.95% | -1.09% | 13.18% | -138.40% | 31.01% | -24.37% | 8.59% | 3.33% | -87.01% | -4.30% | -12.99% | -5.30% | -2.88% | 18.88% | 24.03% | 34.71% | 0.00% |
| Income Tax Expense | 2.00K | -489.00K | -766.00K | 3.00K | 197.00K | -858.00K | 86.00K | 2.00K | -25.00K | -5.94M | 6.00K | -538.00K | 17.00K | -53.00K | 22.00K | -510.00K | 675.00K | -69.00K | 32.00K | -146.00K | 506.00K | -857.00K | -2.05M | -886.00K | -1.76M | -500.00K | 2.50M | 3.00M | 200.00K | -8.64M |
| Net Income | -11.67M | -9.64M | -7.56M | -7.61M | -8.51M | -7.53M | -13.25M | -11.58M | -13.10M | 10.78M | -4.96M | -185.00K | -2.71M | -4.98M | 260.00K | 4.73M | -36.03M | -16.29M | -12.40M | 5.25M | 2.08M | -81.78M | -2.37M | -12.79M | -3.84M | -2.60M | 9.60M | 13.90M | 15.80M | 8.64M |
| Net Income Ratio | -701.08% | -1,285.60% | -870.43% | -2,277.25% | -1,743.44% | -5,932.28% | -15,408.14% | -497.51% | -490.27% | 2,100.97% | -30.20% | -0.77% | -10.38% | -24.73% | 0.93% | 14.77% | -141.04% | -30.88% | -24.43% | 8.84% | 2.67% | -86.11% | -2.30% | -12.15% | -3.64% | -2.41% | 14.98% | 24.56% | 34.27% | 19.72% |
| EPS | -7.12 | -5.95 | -4.76 | -10.38 | -40.22 | -45.75 | -97.89 | -85.09 | -96.34 | 78.00 | -38.18 | -1.50 | -21.95 | -41.94 | 3.00 | 43.50 | -583.97 | -1.89K | -1.46K | 630.00 | 255.00 | -9.98K | -298.79 | -1.68K | -511.51 | -348.71 | 1.29K | 1.86K | 3.56K | 2.55K |
| EPS Diluted | -7.12 | -5.95 | -4.76 | -10.38 | -40.22 | -45.75 | -97.89 | -85.08 | -96.34 | 78.00 | -38.18 | -1.44 | -21.95 | -41.94 | 1.50 | 42.00 | -583.97 | -1.89K | -1.46K | 555.00 | 225.00 | -9.98K | -298.79 | -1.68K | -511.51 | -348.71 | 1.26K | 1.86K | 3.56K | 1.94K |
| Weighted Avg Shares Out | 1.64M | 1.62M | 1.59M | 732.80K | 211.53K | 164.67K | 135.37K | 136.12K | 135.92K | 132.07K | 129.91K | 123.33K | 123.63K | 118.81K | 110.45K | 109.10K | 61.70K | 8.61K | 8.50K | 8.41K | 8.30K | 8.19K | 7.92K | 7.60K | 7.52K | 7.46K | 7.44K | 7.41K | 4.45K | 3.39K |
| Weighted Avg Shares Out (Dil) | 1.64M | 1.62M | 1.59M | 732.80K | 211.53K | 164.67K | 135.37K | 136.13K | 135.92K | 132.07K | 129.91K | 128.85K | 123.63K | 118.81K | 121.89K | 112.69K | 61.70K | 8.61K | 8.50K | 9.46K | 9.43K | 8.19K | 7.92K | 7.60K | 7.52K | 7.46K | 9.71K | 7.44K | 4.45K | 4.49K |
Astrotech Announces Closing of $6.2 Million Registered Direct Offering Priced At-the-Market
AUSTIN, Texas--(BUSINESS WIRE)--Astrotech Corporation (NASDAQ: ASTC), today announced that it has closed its previously announced registered direct offering priced at-the-market under Nasdaq rules of 2,887,906 shares of its common stock at a price of $2.15 per share for aggregate gross...
Astrotech Announces $6.2 Million Registered Direct Offering Priced At-the-Market
AUSTIN, Texas--(BUSINESS WIRE)--Astrotech Corporation (NASDAQ: ASTC), today announced that it has entered into definitive agreements with several institutional investors for the purchase and sale of 2,887,906 shares of Astrotech's common stock, at a purchase price of $2.15 per share, in...
Coronavirus update: CDC says nearly 300,000 excess American deaths have occurred during pandemic
The U.S. death toll from the coronavirus illness COVID-19 rose above 221,000 on Wednesday, according to data aggregated by Johns Hopkins University, and the...
ASTC Stock News: Why Astrotech Stock Is Soaring 160% Today
Astrotech stock is popping Wednesday thanks to news it will work with the Cleveland Clinic to develop a rapid coronavirus breath test.
Astrotech's stock skyrockets after JDA with Cleveland Clinic to develop COVID-19 breath test
Shares of Astrotech Corp. undefined skyrocketed 168% in active trading to pace all premarket gainers Wednesday, after the company said its BreathTech Corp....
Astrotech Announces Pricing of $18.0 Million Upsized Public Offering
Astrotech Corporation (Nasdaq: ASTC), today announced the pricing of a public offering of an aggregate of 7,826,086 shares of common stock, at a purch
Astrotech Subsidiary and Cleveland Clinic Partner to Develop a Rapid COVID-19 Breath Test
Astrotech Corporation’s (NASDAQ: ASTC) subsidiary, BreathTech Corporation announced today that it has signed a joint development agreement (JDA) with
Analyzing Avantor (NYSE:AVTR) and Astrotech (NYSE:ASTC)
Avantor (NYSE:AVTR) and Astrotech (NASDAQ:ASTC) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, risk, valuation, profitability, institutional ownership and earnings. Profitability This table...
Nearly 100 Cool New Worlds Found in Our Cosmic Backyard With Key Help From Citizen Scientists
Citizen scientists and NOIRLab facilities key to discovery of almost 100 nearby cool brown dwarfs. How complete is our census of the Sun’s closest neighbors? Astronomers using NSF’s NOIRLab facilities and a team of data-sleuthing volunteers participating in Backyard Worlds:...
Pandemic and Dangerous Weather Events Underscore Need for Seamless Interoperability Between Public Safety Agencies
The past several months have tested first responders like never before, requiring unprecedented levels of collaboration to help their communities duri
Source: https://incomestatements.info
Category: Stock Reports